PHR Stock Analysis: Buy, Sell, or Hold?
PHR - Phreesia, Inc.
$8.77
-0.42 (-4.57%)
▼
5d:
-10.78%
30d:
-3.2%
90d:
-26.05%
WAIT
LOW Confidence
Analysis Updated: May 14, 2026 12:00 AM ET
Earnings: May 27, 2026
12d
Smart Money Accumulation
PHR is down 10.8% this week, but smart money is accumulating calls. Top strike: $10 2026-07-17 with 1,925 OI. Call ratio: 65% View Scanner →
Strength: 6.9/10
Get Alerted When PHR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: PHR is down 10.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: PHR is down 10.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$30.79
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$19.12
54.1% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 10.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: PHR is currently trading at $8.77, which is considered slightly low relative to its 30-day fair value range of $8.74 to $9.70. From a valuation perspective, the stock is trading at a discount (Forward PE: 6.1) compared to its historical average (10.5). Remarkably, the market is currently pricing in an annual earnings decline of 16.7% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, PHR is in a strong downtrend. The price is currently testing key support at $8.64. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.6% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $16.17 (+75.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PHR is in a strong downtrend. The price is currently testing key support at $8.64. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.6% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $16.17 (+75.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$8.74 -
$9.70
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.8%
Protect Your Profits
Holding PHR? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.6%)
- BULLISH: Trading 75.9% below Wall St target ($16.17)
- WARNING: Recommendation downgraded due to -10.8% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$8.74 -
$9.70
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$8.64
Resistance Level
$10.27
Current Trend
Strong Downtrend
Technical data as of
May 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
6.10
Wall Street Target
$16.17
(+75.9%)
Revenue Growth (YoY)
15.9%
Profit Margin
0.5%
Valuation Discount vs History
-16.7% cheaper
PE vs Historical
6.1 vs 10.5
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-16.7%
(market-implied from PE analysis)
1-Year Target
$8.27
(-10%)
2-Year Target
$7.44
(-19%)
3-Year Target
$6.70
(-27%)
3-Yr Target (if PE normalizes)
(PE: 6→11)
$11.53
(+25%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.0, Growth: 29.2%)
$71.50
(+678%)
Base:
(SPY PE: 6.1, Growth: 29.2%)
$19.80
(+115%)
Bear:
(PE: 5.2, Growth: 29.2%)
$16.83
(+83%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (18x PE), but valuation improves significantly next year (6x PE) as earnings recover.
Forward PE: 18.48 | Forward EPS (Implied): $0.50
Bull Case
$11.10
(+21%)
Analyst growth 15.0%, PE expands to 19.4
Base Case
$9.19
(0%)
Market implied 0.0%, PE stable at 18.5
Bear Case
$7.03
(-24%)
Severe decline -15.0%, PE contracts to 16.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 6.1 to 10.5
Stabilization Target:
$15.81
(+72.1%)
PE Expansion Potential:
+72.1%
Share & Embed Analysis
Last updated: May 14, 2026 4:39 PM ET
Data refreshes hourly during market hours. Next update: 5:39 PM
Data refreshes hourly during market hours. Next update: 5:39 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PHR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
20
Sells
Net
INSIDERS SELLING
Recent Transactions
Allison C Hoffman
SELL
6176 shares
2026-04-20
Yvonne Hui
SELL
1327 shares
2026-04-17
Yvonne Hui
SELL
10063 shares
2026-04-16
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$264 | 55 HOLD |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$32 | 57 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 60 HOLD |
|
EVH
Evolent Health Inc |
STRONG BUY
14 analysts |
$5 | 60 HOLD |
|
BTSG
BrightSpring Health Serv… |
STRONG BUY
12 analysts |
$61 | 67 BUY |
Advanced PHR Option Strategies
Professional options setups generated by AI based on today's PHR price and gamma walls.
